공캡슐 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Empty Capsules Market, valued at USD 3.1 billion in 2023, is projected to grow at a CAGR of 6.3% from 2024 to 2032. This growth is driven by the rising demand for dietary supplements and nutraceuticals, largely fueled by greater health consciousness and the increasing preference for preventive healthcare. Furthermore, the pharmaceutical industry is shifting toward capsule formulations due to their ease of swallowing, ability to mask the taste, and potential for controlled-release delivery, which makes them a preferred choice over traditional tablets.

The market is primarily divided into two categories: gelatin and non-gelatin capsules. The gelatin segment holds a dominant share and is anticipated to grow at a CAGR of 6.5% through 2032. Gelatin capsules are widely used in both the pharmaceutical and dietary supplement industries, owing to their ability to protect sensitive ingredients from moisture and oxygen, thus maintaining product stability. These capsules also offer superior bioavailability, ensuring better absorption of active ingredients. The versatility of gelatin, derived from various animal sources, allows manufacturers to customize formulations, making them suitable for a wide range of consumer preferences and needs.

In terms of applications, the market is segmented into various therapeutic areas, including vitamins and dietary supplements, antibiotics, anti-inflammatory drugs, cardiovascular therapies, and others. The vitamins and dietary supplements segment was the leading contributor in 2023, generating significant revenue. As health-conscious consumers increasingly seek convenient and efficient ways to enhance their nutritional intake, the demand for capsules has surged. Capsules provide an ideal method for delivering these supplements, ensuring effective absorption and bioavailability. The growing aging population and the widespread adoption of preventive healthcare are further boosting the demand for this segment.

The U.S. holds a key position in the North American empty capsules market, accounting for a substantial share. The country's market dominance is supported by a strong pharmaceutical and nutraceutical sector, alongside increasing consumer demand for dietary supplements and the trend toward personalized medicine. The U.S. also benefits from cutting-edge manufacturing technologies and rigorous regulatory standards, which ensure the production of high-quality capsules that meet consumer expectations. Additionally, innovations in capsule formulations and the growing popularity of both vegetarian and gelatin options are further contributing to market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for nutraceuticals and dietary supplements
    • 3.2.1.2 Growth of pharmaceutical industry
    • 3.2.1.3 Preference for capsule-based dosage forms
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Quality control and consistency
    • 3.2.2.2 High production costs
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Gelatin
  • 5.2.1 Porcine gelatin
  • 5.2.2 Bovine derived
  • 5.2.3 Bone meal
  • 5.2.4 Other gelatin capsule types
• 5.3 Non-gelatin
  • 5.3.1 Hydroxypropyl methylcellulose (HPMC)
  • 5.3.2 Pullulan & starch

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Immediate release
• 6.3 Sustained release
• 6.4 Delayed release

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Antibiotic and antibacterial drugs
• 7.3 Vitamins and dietary supplements
• 7.4 Antacid and anti-flatulent preparations
• 7.5 Anti-anemic preparations
• 7.6 Anti-inflammatory drugs
• 7.7 Cardiovascular therapy drugs
• 7.8 Cough and cold drugs
• 7.9 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical
• 8.3 Nutraceutical
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ACG
• 10.2 BioCaps Enterprise
• 10.3 Bright Pharma Caps
• 10.4 CapsCanada Corporation
• 10.5 Chemcaps Limited
• 10.6 Fortcaps Healthcare
• 10.7 HealthCaps India
• 10.8 Lonza Group
• 10.9 Medi-Caps
• 10.10 Nectar Lifesciences
• 10.11 Qualicaps
• 10.12 Shanxi JC Biological Technology
• 10.13 Suheung
• 10.14 Sunil Healthcare